Advertisement

Risk factors associated with contamination of allograft valves in a tissue bank

  • Bruna Sawa
  • Victoria Stadler Tasca Ribeiro
  • Letícia Kraft
  • Luciana Cristina Wollmann
  • Danielle Pegoraro
  • Paula Hansen Suss
  • Felipe Francisco TuonEmail author
Article

Abstract

The contamination of the transport solution used in cardiovascular allografts can occur from different sources. Risk factors associated with positive microbiological test of transport solution have not been reported previously. This study aimed to determine the risk factor for contamination of transport solution used in the heart valve allografts stored in a Brazilian tissue bank. This retrospective study was conducted on all donors of cardiovascular allografts stored in a tissue bank from December 2008 to December 2017. Microbiological cultures for aerobic and anaerobic bacteria, fungi/yeasts were carried out in TS. Clinical variables were included. From 1001 transport solution, 52% were contaminated. A total of 770 microorganisms were identified, and Staphylococcus spp. was identified in 248 isolates (32.2%). Skin bacteria from skin microbiota were the most commonly identified microorganisms (Staphylococcus spp., Cutibacterium spp., Corynebacterium spp., and Bacillus spp.), occurring in 49.6%. The presence of a diagnosis of healthcare-associated infection was not associated with skin contamination (odds ratio [OR] 0.62 [0.41–0.94]; p = 0.014). Conditions like fever, use of antibiotics, and leukocytosis were less likely associated with contamination of transport solution. A longer warm ischemic time was associated with higher frequency of contamination. In the multivariable analysis, warm ischemic time was independently associated with contamination, and antibiotic therapy was a factor that decreased the rate of contamination (p < 0.05). Contamination of transport solution is associated with modifiable risk factors, such as warm ischemic time. Measures to minimize contamination should be employed to avoid unnecessary tissue discharges.

Keywords

Allografts Microbiology Risk factors Tissue banking 

Notes

Compliance with ethical standards

Conflict of interest

Authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee.

References

  1. ANVISA (2015) Boas Práticas em Tecidos humanos para uso terapêutico. Resolução RDC n55Google Scholar
  2. Bravo D, Rigley TH, Gibran N, Strong DM, Newman-Gage H (2000) Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns 26(4):367–378CrossRefGoogle Scholar
  3. Castagnoli C, Alotto D, Cambieri I, Casimiri R, Aluffi M, Stella M, Magliacani G (2003) Evaluation of donor skin viability: fresh and cryopreserved skin using tetrazolioum salt assay. Burns 29(8):759–767CrossRefGoogle Scholar
  4. Centers for Disease, C., & Prevention (2002) Update: allograft-associated bacterial infections–United States, 2002. MMWR Morb Mortal Wkly Rep 51(10):207–210Google Scholar
  5. de By TM, Parker R, Delmo Walter EM, Hetzer R (2012) Cardiovascular tissue banking in Europe. HSR Proc Intensive Care Cardiovasc Anesth 4(4):251–260Google Scholar
  6. Eastlund T (2006) Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank 7(3):147–166.  https://doi.org/10.1007/s10561-006-0003-z CrossRefGoogle Scholar
  7. ECOT (2016) Guide to the quality and safety of organs for transplantation, 6th edn. European Committee on Organ TransplantationGoogle Scholar
  8. Fan YD, Van Hoeck B, Holovska V, Jashari R (2012) Evaluation of decontamination process of heart valve and artery tissues in European Homograft Bank (EHB): a retrospective study of 1,055 cases. Cell Tissue Bank 13(2):297–304.  https://doi.org/10.1007/s10561-011-9255-3 CrossRefGoogle Scholar
  9. Fishman JA, Greenwald MA, Grossi PA (2012) Transmission of infection with human allografts: essential considerations in donor screening. Clin Infect Dis 55(5):720–727.  https://doi.org/10.1093/cid/cis519 CrossRefGoogle Scholar
  10. Germain M, Strong DM, Dowling G, Mohr J, Duong A, Garibaldi A, Cardiac Tissue Working g (2016) Disinfection of human cardiac valve allografts in tissue banking: systematic review report. Cell Tissue Bank 17(4):593–601.  https://doi.org/10.1007/s10561-016-9570-9 CrossRefGoogle Scholar
  11. Hoquel R, Rashid Z, Sarkar SK (2007) Antibiotic sterilization of cadaveric homograft aortic valve for clinical use. Bangladesh Med Res Counc Bull 33(2):69–72CrossRefGoogle Scholar
  12. Ireland L, Spelman D (2005) Bacterial contamination of tissue allografts—experiences of the donor tissue bank of Victoria. Cell Tissue Bank 6(3):181–189.  https://doi.org/10.1007/s10561-005-7365-5 CrossRefGoogle Scholar
  13. Jashari R, Tabaku M, Van Hoeck B, Cochez C, Callant M, Vanderkelen A (2007) Decontamination of heart valve and arterial allografts in the European Homograft Bank (EHB): comparison of two different antibiotic cocktails in low temperature conditions. Cell Tissue Bank 8(4):247–255.  https://doi.org/10.1007/s10561-007-9040-5 CrossRefGoogle Scholar
  14. Kowalski JB, Merritt K, Gocke D, Osborne J (2012a) Assessment of bioburden on human and animal tissues: part 2–results of testing of human tissue and qualification of a composite sample for routine bioburden determination. Cell Tissue Bank 13(3):431–439.  https://doi.org/10.1007/s10561-012-9296-2 CrossRefGoogle Scholar
  15. Kowalski JB, Mosley GA, Merritt K, Osborne J (2012b) Assessment of bioburden on human and animal tissues: Part 1–results of method development and validation studies. Cell Tissue Bank 13(1):129–138.  https://doi.org/10.1007/s10561-010-9238-9 CrossRefGoogle Scholar
  16. Len O, Garzoni C, Lumbreras C, Molina I, Meije Y, Pahissa A, Hosts ESG, ESCMID Study Group of Infection in Compromised Hosts (ESGICH) (2014) Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 20(Suppl 7):10–18.  https://doi.org/10.1111/1469-0691.12557 CrossRefGoogle Scholar
  17. Martinez OV, Malinin TI, Valla PH, Flores A (1985) Postmortem bacteriology of cadaver tissue donors: an evaluation of blood cultures as an index of tissue sterility. Diagn Microbiol Infect Dis 3(3):193–200CrossRefGoogle Scholar
  18. Paolin A, Trojan D, Petit P, Coato P, Rigoli R (2017) Evaluation of allograft contamination and decontamination at the Treviso Tissue Bank Foundation: a retrospective study of 11,129 tissues. PLoS ONE 12(3):e0173154.  https://doi.org/10.1371/journal.pone.0173154 CrossRefGoogle Scholar
  19. Saegeman V, Verhaegen J, Lismont D, Verduyckt B, De Rijdt T, Ectors N (2009) Influence of postmortem time on the outcome of blood cultures among cadaveric tissue donors. Eur J Clin Microbiol Infect Dis 28(2):161–168.  https://doi.org/10.1007/s10096-008-0609-0 CrossRefGoogle Scholar
  20. Segur JM, Suso S, Garcia S, Combalia A, Farinas O, Llovera A (2000) The procurement team as a factor of bone allograft contamination. Cell Tissue Bank 1(2):117–119.  https://doi.org/10.1023/A:1010136931919 CrossRefGoogle Scholar
  21. Serafini A, Riello E, Trojan D, Cogliati E, Palu G, Manganelli R, Paolin A (2016) Evaluation of new antibiotic cocktails against contaminating bacteria found in allograft tissues. Cell Tissue Bank 17(4):619–628.  https://doi.org/10.1007/s10561-016-9581-6 CrossRefGoogle Scholar
  22. Tabaku M, Jashari R, Carton HF, Du Verger A, Van Hoeck B, Vanderkelen A (2004) Processing of cardiovascular allografts: effectiveness of European Homograft Bank (EHB) antimicrobial treatment (cool decontamination protocol with low concentration of antibiotics). Cell Tissue Bank 5(4):261–266.  https://doi.org/10.1007/s10561-004-1440-1 CrossRefGoogle Scholar
  23. Tuomisto S, Karhunen PJ, Vuento R, Aittoniemi J, Pessi T (2013) Evaluation of postmortem bacterial migration using culturing and real-time quantitative PCR. J Forensic Sci 58(4):910–916.  https://doi.org/10.1111/1556-4029.12124 CrossRefGoogle Scholar
  24. van Kats JP, van Tricht C, van Dijk A, van der Schans M, van den Bogaerdt A, Petit PL, Bogers AJ (2010) Microbiological examination of donated human cardiac tissue in heart valve banking. Eur J Cardiothorac Surg 37(1):163–169.  https://doi.org/10.1016/j.ejcts.2009.07.011 CrossRefGoogle Scholar
  25. Vehmeyer S, Wolkenfelt J, Deijkers R, Petit P, Brand R, Bloem R (2002) Bacterial contamination in postmortem bone donors. Acta Orthop Scand 73(6):678–683.  https://doi.org/10.1080/000164702321039679 CrossRefGoogle Scholar
  26. WHO (2003) Consultation on the ethic. Access and safety in tissue and organ transplantation: issues of global concern. Retrieved from Madrid, SpainGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Division of Infectious Diseases, School of MedicinePontifícia Universidade Católica do ParanáCuritibaBrazil
  2. 2.Human Tissues BankPontifícia Universidade Católica do ParanáCuritibaBrazil
  3. 3.Escola de MedicinaPontifícia Universidade Católica do ParanáCuritibaBrazil

Personalised recommendations